Treatment for Mild Chronic Hypertension during Pregnancy.

Authors

Alan T Tita
Jeff M Szychowski
Kim Boggess
Lorraine Dugoff
Baha Sibai
Kirsten Lawrence
Brenna L Hughes
Joseph Bell
Kjersti Aagaard
Rodney K Edwards
Dotum Ogunyemi, Beaumont Health Resident

Document Type

Article

Publication Date

5-12-2022

Publication Title

The New England journal of medicine

Abstract

BACKGROUND: The benefits and safety of the treatment of mild chronic hypertension (blood pressure, <160/100 mm Hg) during pregnancy are uncertain. Data are needed on whether a strategy of targeting a blood pressure of less than 140/90 mm Hg reduces the incidence of adverse pregnancy outcomes without compromising fetal growth.

METHODS: In this open-label, multicenter, randomized trial, we assigned pregnant women with mild chronic hypertension and singleton fetuses at a gestational age of less than 23 weeks to receive antihypertensive medications recommended for use in pregnancy (active-treatment group) or to receive no such treatment unless severe hypertension (systolic pressure, ≥160 mm Hg; or diastolic pressure, ≥105 mm Hg) developed (control group). The primary outcome was a composite of preeclampsia with severe features, medically indicated preterm birth at less than 35 weeks' gestation, placental abruption, or fetal or neonatal death. The safety outcome was small-for-gestational-age birth weight below the 10th percentile for gestational age. Secondary outcomes included composites of serious neonatal or maternal complications, preeclampsia, and preterm birth.

RESULTS: A total of 2408 women were enrolled in the trial. The incidence of a primary-outcome event was lower in the active-treatment group than in the control group (30.2% vs. 37.0%), for an adjusted risk ratio of 0.82 (95% confidence interval [CI], 0.74 to 0.92; P

CONCLUSIONS: In pregnant women with mild chronic hypertension, a strategy of targeting a blood pressure of less than 140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension, with no increase in the risk of small-for-gestational-age birth weight. (Funded by the National Heart, Lung, and Blood Institute; CHAP ClinicalTrials.gov number, NCT02299414.).

Volume

386

Issue

19

First Page

1781

Last Page

1792

Recommended Citation

Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al [Ogunyemi D] Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2. PMID: 35363951.

DOI

10.1056/NEJMoa2201295

ISSN

1533-4406

PubMed ID

35363951